Cosmos Pharmaceuticals Inc.

Cosmos Pharmaceuticals Inc. had the privilege of being invited to the MEDevice Conference in Boston this week as part of the Innovation Company Showcase. It was an incredible experience to engage with and learn from some of the most renowned leaders in the medical device industry. We want to extend our thanks to MD&M for hosting such an impactful event. A special shoutout to Richard Meiklejohn and Kyle Kruse 🚀 for hosting the MedTech Health Tech Mixer and for your continued support of healthcare entrepreneurs. Building on the energy from this conference, the Cosmos team is excited to present our medication adherence solution, powered by FortisKap, next week in NYC on Wednesday. Stay tuned for more details!

🌟 Cosmos Pharmaceuticals Inc. is excited to be at the NJx Venture Summit today, showcasing our Medication Adherence Solution! 🚀 Joseph W. White, Chief Innovation Officer of Cosmos Pharmaceuticals Inc., is exhibiting the cutting-edge FortisKap device, designed to revolutionize medication adherence. Our mission at Cosmos is to empower patients and improve health outcomes by providing real-time data between pharmacy visits, ensuring no one slips through the cracks. During today’s summit, Joe is speaking about the pivotal role Cosmos is playing in transforming healthcare, especially for those transitioning to outpatient care. The entrepreneurial spirit is alive here at NJx, and it’s incredible to be surrounded by fellow innovators, venture capitalists, and leaders driving the next wave of biotech, medtech, and healthcare solutions. A huge thank you to the organizers for facilitating such a valuable platform for startups like Cosmos to connect, learn, and grow. A special shout out to @Don Samoil for the invitation and continued support of our vision! #Innovation #HealthcareTech #VentureSummit #MedTech #CosmosPharmaceuticals #HealthcareInnovation #FortisKap #MedicationAdherence #NJxSummit2024

🕊️ International Overdose Awareness Day: Remembering Lives, Preventing Tragedies 🕊️ Today, on International Overdose Awareness Day, we at Cosmos Pharmaceuticals Inc. stand in solidarity with communities around the world to remember those lost to overdoses and to pledge our commitment to preventing these tragedies in the future. Overdose death is a heartbreaking and preventable loss, and at Cosmos, we believe that innovative technology can be a powerful tool in the fight against it. Through our FortisKap device, we are working to ensure that patients remain engaged with their prescribed treatments, providing healthcare providers with real-time insights that can make the difference between life and death. Our mission is not just about advancing technology—it’s about saving lives. By supporting healthcare providers with tools that enhance medication adherence and provide critical data, we aim to reduce the risk of overdoses and contribute to a future where such losses are far less frequent. As we honor the lives lost to overdoses, we are more determined than ever to be part of the solution. On this day of awareness, we also recognize the importance of continued education, support, and advocacy to combat the stigma associated with addiction. Together, we can create a safer, healthier future. #InternationalOverdoseAwarenessDay #RememberingLives #PreventingTragedies #CosmosPharmaceuticals #FortisKap #HealthInnovation #PatientSafety

🕊️ International Overdose Awareness Day: Remembering Lives, Preventing Tragedies 🕊️ Today, on International Overdose Awareness Day, we at Cosmos Pharmaceuticals Inc. stand in solidarity with communities around the world to remember those lost to overdoses and to pledge our commitment to preventing these tragedies in the future. Overdose death is a heartbreaking and preventable loss, and at Cosmos, we believe that innovative technology can be a powerful tool in the fight against it. Through our FortisKap device, we are working to ensure that patients remain engaged with their prescribed treatments, providing healthcare providers with real-time insights that can make the difference between life and death. Our mission is not just about advancing technology—it’s about saving lives. By supporting healthcare providers with tools that enhance medication adherence and provide critical data, we aim to reduce the risk of overdoses and contribute to a future where such losses are far less frequent. As we honor the lives lost to overdoses, we are more determined than ever to be part of the solution. On this day of awareness, we also recognize the importance of continued education, support, and advocacy to combat the stigma associated with addiction. Together, we can create a safer, healthier future. #InternationalOverdoseAwarenessDay #RememberingLives #PreventingTragedies #CosmosPharmaceuticals #FortisKap #HealthInnovation #PatientSafety

Today is the 2024 CharmHealth Innovation Challenge in Washington D.C. at the 📍Grand Hyatt! Cosmos Pharmaceuticals Inc. is showcasing its flagship product, FortisKap, and our medication adherence platform! Come meet our team including in Constitution A ball room!

Cosmos Pharmaceuticals Inc. excited to announce that Alexander Colton will be attending the upcoming SUD SPRINT in-person networking event on Thursday, August 22nd, 2024, at Babson College in Boston. The Cosmos team is looking forward to connecting with fellow leaders, innovators, and industry professionals who are dedicated to finding solutions for substance use disorders. If you are attending, please feel free to reach out to Alexander Colton! He is eager to discuss the Cosmos medication adherence platform and its significant benefits to the Substance Use Disorder community, as well as the broader Behavioral Health vertical. Looking forward to engaging conversations and meaningful connections at the event! #Networking #SubstanceUseDisorder #BehavioralHealth #HealthcareInnovation #CosmosPharmaceuticals #Entrepreneurship

🌟 An Exciting Week from Cosmos Pharmaceuticals Inc.! 🌟 We’re thrilled to announce that Cosmos has been selected to participate in the 2024 CharmHealth Innovation Challenge in Washington D.C. from August 23-25! This year saw an incredible pool of applicants, and it’s an honor to be chosen to pitch our innovative solutions. Alexander Colton, Joseph W. White and Josh Bayer will be in attendance! 📍 Join Us at the Grand Hyatt: We’ll be showcasing our device enabled medication adherence platform during a poster session in the Innovation Exhibit. I’m looking forward to sharing how our technology enhances patient well-being and reduces hospital readmissions. 🏆 A Step Towards Transformation: Attendees’ votes will determine the top six finalists, who will then have the opportunity to present on stage. Winners will receive cash prizes, awards, and further opportunities for investment through the Bioverge + CharmHealth Digital Transformation fund. A big thank you to CharmHealth for hosting this incredible event and providing food and accommodation during our stay. Let’s make healthcare better together! See you in DC!

🚀Exciting Announcement from Cosmos Pharmaceuticals Inc.! 🚀 Cosmos Pharmaceuticals Inc. Accepted to the Substance Use Disorders Ventures Program at Massachusetts Institute of Technology in Close Collaboration with The National Institutes of Health & The National Institute on Drug Abuse (NIDA). 🌟 We are thrilled to share that Cosmos Pharmaceuticals Inc. has been selected to participate in the 2024-2025 Substance Use Disorder (SUD) Ventures program at the Massachusetts Institute of Technology. SUD Ventures is an immersive hybrid bootcamp featuring live expert webinars and a week-long in-person event at MIT in Cambridge, MA. The cohort will collaborate to address critical issues in SUD treatment, drug delivery and outcomes, and solutions for vulnerable populations. The program will culminate in a pitch event where Alexander Colton and Joseph W. White White will engage with investors, healthcare professionals, and previous MIT entrepreneurs in a hands-on environment. This experience will bring together healthcare, government, and commercialization experts to help ventures like Cosmos make a lasting and positive impact on the Opioid & Mental Health Crisis! A note from the program: “According to the Centers for Disease Control and Prevention, one in seven adults in the United States will experience a substance use disorder (SUD) during their lifetime. If you live in the US, you likely know of a friend, family member, or colleague who has been affected by SUD. At the Substance Use Disorder (SUD) Ventures program, our goal is to fuel the next generation of innovation in this space.” #MedicationAdherence #CommunityEngagement #Entrepreneurship #MentalHealthMatters #BehavioralHealth #HealthcareInnovation

Exciting News from Cosmos Pharmaceuticals Inc.! We are eager to start the conversation about medication adherence in Alabama. This is an exciting new opportunity that will bring the right at-home care to patients in need. Our clinical trials in Delaware, Maryland, and Virginia are slated for Q4 of this year, and our early adopter slots are filling up quickly for the new year. If you are interested in enhancing your personal medication adherence, Cosmos is here to guide you through the process. Please feel free to reach out to Alexander Colton or Joseph W. White White for more information. Together, let’s make a difference in medication adherence!